We specialize in optimizing bioavailability, stability, and delivery methods across many dosage forms. Through robust QA oversight—whether addressing complex solubility challenges or fine-tuning release profiles—we ensure each formulation is designed for maximum efficacy and safety. Our end-to-end approach integrates seamlessly with analytical testing and manufacturing to deliver reliable, patient-focused solutions. Explore our features to see how we transform demanding formulation challenges into successful outcomes.
Benuvia’s formulation expertise was a game-changer for our project. Their team’s ability to tailor solutions and optimize stability gave us a competitive edge. The seamless integration with their manufacturing services saved us time and ensured our product met the highest quality standards.
Specialty Pharmaceutical Client
Director of Product Development
Our formulation development services deliver results that align with your goals and regulatory requirements.
We excel in solving complex formulation challenges by developing innovative solutions that enhance bioavailability, stability, and patient compliance. Our expertise spans niche and mainstream products, ensuring customized results tailored to your specific needs and market requirements.
Benuvia’s advanced technology and streamlined workflows enable faster transitions from R&D to market while maintaining quality. We identify potential roadblocks early and implement efficient processes to minimize delays, ensuring timely completion of every project milestone and ultimate market readiness.
Our formulations are meticulously designed to meet stringent FDA, EMA, and global standards, ensuring compliance at every step. With a deep understanding of regulatory guidelines, we simplify the approval process, reducing risks and providing a clear pathway to successful product submissions.
Every formulation undergoes rigorous Quality Assurance oversight, ensuring precision in bioavailability, stability, and delivery methods. QA qualifies raw material suppliers, monitors processes, and ensures consistency across batches, providing patient-focused solutions that meet the highest safety and efficacy standards.
Our adaptable processes seamlessly scale from small trials to full-scale manufacturing, providing consistent quality and support. We ensure your project evolves with market demands, delivering precision and reliability at every stage of development and commercialization.
Benuvia brings deep experience across oral, injectable, topical, and sublingual dosage forms, applying innovative strategies to each. No matter the complexity, our solutions ensure precision, consistency, and exceptional results tailored to meet your product’s unique requirements.
Explore our formulation development case studies to see how Benuvia has transformed challenges into innovative solutions. Discover the expertise, technology, and precision that drive our success and yours.
Dr. Aruna Earla serves as the Director of the Research and Development group at Benuvia Operations, where she has been working since 2020. She is involved in the process development of Active Pharmaceutical Ingredients (APIs). With approximately 20 years of experience in pharmaceutical research, development, and manufacturing within the CRO and CDMO sectors, Dr. Earla brings a wealth of expertise to her role. She holds an M.S. in Organic Chemistry, an M.S. in Biotechnology, and a Ph.D. in Organic Chemistry. Her extensive experience in organic synthesis covers a wide range of chemistries, including cannabinoids and psychedelics. Dr. Earla’s contributions are significant, spanning from initial route scouting to the commercial manufacturing of APIs. Before joining Benuvia, she held Research Scientist positions at Alembic, Dr. Reddy’s, Olon-Ricerca Biosciences, and Nanosyn.
"*" indicates required fields